Topical antifungal treatments for tinea cruris and tinea corporis
Magdy El-Gohary(University of Southampton), Paul Little(University of Antwerp), P. R. Hearn, Michael Moore(Indiana University School of Medicine), Beth Stuart(Queen Mary University of London), Liz Doney(University of Nottingham), Hana Burgess(Drug Safety Research Unit), Elizabeth M. Johnson(Bristol-Myers Squibb (Germany))
Cited by 34
Related Papers
Voriconazole Treatment for Less‐Common, Emerging, or Refractory Fungal Infections
|Clinical Infectious Diseases|2003|680
MAIT cells are activated during human viral infections
|Nature Communications|2016|526
Effects of internet-based training on antibiotic prescribing rates for acute respiratory-tract infections: a multinational, cluster, randomised, factorial, controlled trial
|The Lancet|2013|440
Continued high rates of antibiotic prescribing to adults with respiratory tract infection: survey of 568 UK general practices
|BMJ Open|2014|285
Physical activity, mental health and well-being of adults during initial COVID-19 containment strategies: A multi-country cross-sectional analysis
|Journal of science and medicine in sport|2020|281